ArticleFrontiers in endocrinology2026

Cardiorenal protective effects of dapagliflozin combined with valsartan in patients with type 2 diabetes mellitus and hypertension: a retrospective cohort study.

Zhengrong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.